81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals shares outstanding 1990–2026What are shares outstanding? Shares outstanding are all the shares a company has issued that investors hold, insiders included. Their number times the share price is the market value.
Vertex Pharmaceuticals had 253,461,000 shares outstanding on 9 November 2026. Vertex Pharmaceuticals had 255.83M diluted shares on average over the last twelve months, down 1.3% on the twelve months before. In fiscal year 2025 the average was 258.00M.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
Shares outstanding
Change on the year
| Fiscal year | Period ending | Shares outstanding | Change on the year | Basic shares |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 255.83M | -1.27% | 253.85M |
| FY2025 | 31 Dec 2025 | 258.00M | +0.04% | 255.70M |
| FY2024 | 31 Dec 2024 | 257.90M | -1.00% | 257.50M |
| FY2023 | 31 Dec 2023 | 260.50M | +0.54% | 257.70M |
| FY2022 | 31 Dec 2022 | 259.10M | -0.31% | 256.10M |
| FY2021 | 31 Dec 2021 | 259.90M | -1.33% | 257.70M |
| FY2020 | 31 Dec 2020 | 263.40M | +1.04% | 259.84M |
| FY2019 | 31 Dec 2019 | 260.67M | +0.57% | 256.73M |
| FY2018 | 31 Dec 2018 | 259.19M | +2.35% | 254.29M |
| FY2017 | 31 Dec 2017 | 253.23M | +3.49% | 248.86M |
| FY2016 | 31 Dec 2016 | 244.69M | +1.40% | 243.59M |
| FY2015 | 31 Dec 2015 | 241.31M | +2.55% | 240.84M |
| FY2014 | 31 Dec 2014 | 235.31M | +4.62% | 234.92M |
| FY2013 | 31 Dec 2013 | 224.91M | +6.11% | 224.83M |
| FY2012 | 31 Dec 2012 | 211.95M | +1.50% | 211.95M |
| FY2011 | 31 Dec 2011 | 208.81M | +4.19% | 204.89M |
| FY2010 | 31 Dec 2010 | 200.40M | +15.67% | 200.40M |
| FY2009 | 31 Dec 2009 | 173.26M | +23.27% | 173.26M |
| FY2008 | 31 Dec 2008 | 140.56M | +8.97% | 140.56M |
| FY2007 | 31 Dec 2007 | 128.99M | +13.92% | 128.99M |
| FY2006 | 31 Dec 2006 | 113.22M | +26.87% | 113.22M |
| FY2005 | 31 Dec 2005 | 89.24M | +13.58% | 89.24M |
| FY2004 | 31 Dec 2004 | 78.57M | +2.03% | 78.57M |
| FY2003 | 31 Dec 2003 | 77.00M | +1.66% | 77.00M |
| FY2002 | 31 Dec 2002 | 75.75M | +1.73% | 75.75M |
| FY2001 | 31 Dec 2001 | 74.46M | +10.02% | 74.46M |
| FY2000 | 31 Dec 2000 | 67.68M | +32.62% | 67.68M |
| FY1999 | 31 Dec 1999 | 51.04M | +0.87% | 51.04M |
| FY1998 | 31 Dec 1998 | 50.60M | +4.27% | 50.60M |
| FY1997 | 31 Dec 1997 | 48.53M | +29.81% | 48.53M |
| FY1996 | 31 Dec 1996 | 37.38M | +9.54% | 37.38M |
| FY1995 | 31 Dec 1995 | 34.13M | +8.59% | 34.13M |
| FY1994 | 31 Dec 1994 | 31.43M | +25.71% | 31.43M |
| FY1993 | 31 Dec 1993 | 25.00M | +2.94% | 25.00M |
| FY1992 | 31 Dec 1992 | 24.29M | +66.17% | 24.29M |
| FY1991 | 31 Dec 1991 | 14.62M | -25.72% | 14.62M |
| FY1990 | 31 Dec 1990 | 19.68M | — | 19.68M |
| Quarter | Period ending | Shares outstanding | Growth on a year before | Basic shares |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 255.20M | -0.93% | 253.50M |
| Q2 FY2026 | 30 Jun 2026 | 255.70M | -1.24% | 253.90M |
| Q1 FY2026 | 31 Mar 2026 | 256.30M | -1.23% | 254.10M |
| Q4 FY2025 | 31 Dec 2025 | 256.10M | -1.69% | 253.90M |
| Q3 FY2025 | 30 Sept 2025 | 257.60M | -1.30% | 255.60M |
| Q2 FY2025 | 30 Jun 2025 | 258.90M | +0.31% | 256.70M |
| Q1 FY2025 | 31 Mar 2025 | 259.50M | -0.61% | 256.90M |
| Q4 FY2024 | 31 Dec 2024 | 260.50M | -0.15% | 257.50M |
| Q3 FY2024 | 30 Sept 2024 | 261.00M | +0.15% | 258.00M |
| Q2 FY2024 | 30 Jun 2024 | 258.10M | -0.88% | 258.10M |
| Q1 FY2024 | 31 Mar 2024 | 261.10M | +0.31% | 258.20M |
| Q4 FY2023 | 31 Dec 2023 | 260.90M | +0.23% | 257.70M |
| Q3 FY2023 | 30 Sept 2023 | 260.60M | +0.42% | 258.00M |
| Q2 FY2023 | 30 Jun 2023 | 260.40M | +0.66% | 257.70M |
| Q1 FY2023 | 31 Mar 2023 | 260.30M | +0.93% | 257.40M |
| Q4 FY2022 | 31 Dec 2022 | 260.30M | +1.28% | 256.90M |
| Q3 FY2022 | 30 Sept 2022 | 259.50M | -0.08% | 256.50M |
| Q2 FY2022 | 30 Jun 2022 | 258.70M | -0.89% | 255.90M |
| Q1 FY2022 | 31 Mar 2022 | 257.90M | -1.53% | 255.10M |
| Q4 FY2021 | 31 Dec 2021 | 257.00M | -2.32% | 254.60M |
| Q3 FY2021 | 30 Sept 2021 | 259.71M | -1.66% | 257.88M |
| Q2 FY2021 | 30 Jun 2021 | 261.02M | -0.90% | 258.99M |
| Q1 FY2021 | 31 Mar 2021 | 261.92M | -0.61% | 259.37M |
| Q4 FY2020 | 31 Dec 2020 | 263.11M | +0.38% | 260.04M |
| Q3 FY2020 | 30 Sept 2020 | 264.08M | +1.38% | 260.39M |
| Q2 FY2020 | 30 Jun 2020 | 263.40M | +1.38% | 259.64M |
| Q1 FY2020 | 31 Mar 2020 | 263.52M | +1.28% | 259.82M |
| Q4 FY2019 | 31 Dec 2019 | 262.11M | +0.88% | 258.00M |
| Q3 FY2019 | 30 Sept 2019 | 260.47M | +0.26% | 256.95M |
| Q2 FY2019 | 30 Jun 2019 | 259.82M | +0.48% | 256.15M |
| Q1 FY2019 | 31 Mar 2019 | 260.18M | +0.64% | 255.70M |
| Q4 FY2018 | 31 Dec 2018 | 259.81M | +1.17% | 254.87M |
| Q3 FY2018 | 30 Sept 2018 | 259.79M | +3.80% | 254.91M |
| Q2 FY2018 | 30 Jun 2018 | 258.58M | +2.76% | 254.14M |
| Q1 FY2018 | 31 Mar 2018 | 258.53M | +3.95% | 253.23M |
| Q4 FY2017 | 31 Dec 2017 | 256.80M | +3.65% | 251.56M |
| Q3 FY2017 | 30 Sept 2017 | 250.27M | +2.18% | 250.27M |
| Q2 FY2017 | 30 Jun 2017 | 251.64M | +2.93% | 247.52M |
| Q1 FY2017 | 31 Mar 2017 | 248.70M | +2.00% | 246.02M |
| Q4 FY2016 | 31 Dec 2016 | 247.76M | +1.96% | 245.45M |
| Q3 FY2016 | 30 Sept 2016 | 244.92M | +1.22% | 242.76M |
| Q2 FY2016 | 30 Jun 2016 | 244.48M | +1.55% | 244.48M |
| Q1 FY2016 | 31 Mar 2016 | 243.83M | +1.81% | 243.83M |
| Q4 FY2015 | 31 Dec 2015 | 242.99M | +1.98% | 239.48M |
| Q3 FY2015 | 30 Sept 2015 | 241.97M | +2.47% | 241.97M |
| Q2 FY2015 | 30 Jun 2015 | 240.76M | +2.97% | 240.76M |
| Q1 FY2015 | 31 Mar 2015 | 239.49M | +2.84% | 239.28M |
| Q4 FY2014 | 31 Dec 2014 | 238.27M | +1.08% | 237.84M |
| Q3 FY2014 | 30 Sept 2014 | 236.14M | +2.44% | 236.11M |
| Q2 FY2014 | 30 Jun 2014 | 233.81M | +5.29% | 233.81M |
| Q1 FY2014 | 31 Mar 2014 | 232.89M | +8.11% | 232.11M |
| Q4 FY2013 | 31 Dec 2013 | 235.72M | +9.84% | 231.26M |
| Q3 FY2013 | 30 Sept 2013 | 230.51M | +7.83% | 229.16M |
| Q2 FY2013 | 30 Jun 2013 | 222.05M | +5.07% | 219.87M |
| Q1 FY2013 | 31 Mar 2013 | 215.42M | -1.75% | 215.40M |
| Q4 FY2012 | 31 Dec 2012 | 214.61M | -2.12% | 214.61M |
| Q3 FY2012 | 30 Sept 2012 | 213.77M | -2.54% | 213.12M |
| Q2 FY2012 | 30 Jun 2012 | 211.34M | +3.39% | 211.34M |
| Q1 FY2012 | 31 Mar 2012 | 219.26M | +8.37% | 208.02M |
| Q4 FY2011 | 31 Dec 2011 | 219.26M | +8.37% | 208.02M |
| Q3 FY2011 | 30 Sept 2011 | 219.35M | +9.19% | 206.00M |
| Q2 FY2011 | 30 Jun 2011 | 204.41M | +2.00% | 204.41M |
| Q1 FY2011 | 31 Mar 2011 | 202.33M | +1.71% | 202.33M |
| Q4 FY2010 | 31 Dec 2010 | 202.33M | +1.71% | 201.37M |
| Q3 FY2010 | 30 Sept 2010 | 200.89M | +12.39% | 200.89M |
| Q2 FY2010 | 30 Jun 2010 | 200.40M | +16.13% | 200.40M |
| Q1 FY2010 | 31 Mar 2010 | 198.94M | +27.64% | 198.94M |
| Q4 FY2009 | 31 Dec 2009 | 198.94M | +27.64% | 198.94M |
| Q3 FY2009 | 30 Sept 2009 | 178.74M | +27.57% | 178.74M |
| Q2 FY2009 | 30 Jun 2009 | 172.56M | +24.39% | 172.56M |
| Q1 FY2009 | 31 Mar 2009 | 155.86M | +15.91% | 155.86M |
| Q4 FY2008 | 31 Dec 2008 | 155.86M | +15.91% | 148.86M |
| Q3 FY2008 | 30 Sept 2008 | 140.11M | +7.77% | 140.11M |
| Q2 FY2008 | 30 Jun 2008 | 138.73M | +7.31% | 138.73M |
| Q1 FY2008 | 31 Mar 2008 | 134.47M | +6.93% | 134.47M |
| Q4 FY2007 | 31 Dec 2007 | 134.47M | +6.93% | 130.81M |
| Q3 FY2007 | 30 Sept 2007 | 130.01M | +15.25% | 130.01M |
| Q2 FY2007 | 30 Jun 2007 | 129.27M | +19.12% | 129.27M |
| Q1 FY2007 | 31 Mar 2007 | 125.76M | +17.05% | 125.76M |
| Q4 FY2006 | 31 Dec 2006 | 125.76M | +17.05% | 124.06M |
| Q3 FY2006 | 30 Sept 2006 | 112.80M | +19.25% | 112.80M |
| Q2 FY2006 | 30 Jun 2006 | 108.52M | +31.90% | 108.52M |
| Q1 FY2006 | 31 Mar 2006 | 107.44M | +35.27% | 107.44M |
| Q4 FY2005 | 31 Dec 2005 | 107.44M | +35.27% | 107.44M |
| Q3 FY2005 | 30 Sept 2005 | 94.59M | +20.13% | 94.59M |
| Q2 FY2005 | 30 Jun 2005 | 82.27M | +4.40% | 82.27M |
| Q1 FY2005 | 31 Mar 2005 | 79.43M | +1.71% | 79.43M |
| Q4 FY2004 | 31 Dec 2004 | 79.43M | +1.71% | 79.08M |
| Q3 FY2004 | 30 Sept 2004 | 78.74M | +2.17% | 78.74M |
| Q2 FY2004 | 30 Jun 2004 | 78.81M | +2.66% | 78.81M |
| Q1 FY2004 | 31 Mar 2004 | 78.09M | +2.20% | 78.09M |
| Q4 FY2003 | 31 Dec 2003 | 78.09M | +2.20% | 77.77M |
| Q3 FY2003 | 30 Sept 2003 | 77.07M | +1.43% | 77.07M |
| Q2 FY2003 | 30 Jun 2003 | 76.76M | +1.46% | 76.76M |
| Q1 FY2003 | 31 Mar 2003 | 76.41M | +1.66% | 76.41M |
| Q4 FY2002 | 31 Dec 2002 | 76.41M | +1.66% | 76.20M |
| Q3 FY2002 | 30 Sept 2002 | 75.98M | +1.74% | 75.98M |
| Q2 FY2002 | 30 Jun 2002 | 75.66M | +25.40% | 75.66M |
| Q1 FY2002 | 31 Mar 2002 | 75.16M | +25.25% | 75.16M |
| Q4 FY2001 | 31 Dec 2001 | 75.16M | +25.25% | 74.90M |
| Q3 FY2001 | 30 Sept 2001 | 74.68M | +38.70% | 74.68M |
| Q2 FY2001 | 30 Jun 2001 | 60.34M | +2.36% | 60.34M |
| Q1 FY2001 | 31 Mar 2001 | 60.01M | +15.57% | 60.01M |
| Q4 FY2000 | 31 Dec 2000 | 60.01M | +15.57% | 59.61M |
| Q3 FY2000 | 30 Sept 2000 | 53.84M | +5.43% | 53.84M |
| Q2 FY2000 | 30 Jun 2000 | 58.95M | +15.67% | 52.64M |
| Q1 FY2000 | 31 Mar 2000 | 51.93M | +3.27% | 51.93M |
| Q4 FY1999 | 31 Dec 1999 | 51.93M | +3.27% | 51.64M |
| Q3 FY1999 | 30 Sept 1999 | 51.07M | +11.02% | 51.07M |
| Q2 FY1999 | 30 Jun 1999 | 50.96M | +4.00% | 50.96M |
| Q1 FY1999 | 31 Mar 1999 | 50.29M | +1.77% | 50.29M |
| Q4 FY1998 | 31 Dec 1998 | 50.29M | +1.77% | 50.29M |
| Q3 FY1998 | 30 Sept 1998 | 46.00M | -6.44% | 46.00M |
| Q2 FY1998 | 30 Jun 1998 | 49.00M | +5.00% | 49.00M |
| Q1 FY1998 | 31 Mar 1998 | 49.41M | +10.75% | 49.41M |
| Q4 FY1997 | 31 Dec 1997 | 49.41M | +10.75% | 49.41M |
| Q3 FY1997 | 30 Sept 1997 | 49.17M | +32.67% | 49.17M |
| Q2 FY1997 | 30 Jun 1997 | 46.67M | +33.93% | 46.67M |
| Q1 FY1997 | 31 Mar 1997 | 44.62M | +30.87% | 44.62M |
| Q4 FY1996 | 31 Dec 1996 | 44.62M | +30.87% | 44.62M |
| Q3 FY1996 | 30 Sept 1996 | 37.06M | +7.42% | 37.06M |
| Q2 FY1996 | 30 Jun 1996 | 34.84M | +0.66% | 34.84M |
| Q1 FY1996 | 31 Mar 1996 | 34.09M | +1.55% | 34.09M |
| Q4 FY1995 | 31 Dec 1995 | 34.09M | +1.55% | 33.01M |
| Q3 FY1995 | 30 Sept 1995 | 34.50M | +6.15% | 34.50M |
| Q2 FY1995 | 30 Jun 1995 | 34.62M | +13.29% | 34.62M |
| Q1 FY1995 | 31 Mar 1995 | 33.57M | +15.40% | 33.57M |
| Q4 FY1994 | 31 Dec 1994 | 33.57M | +15.40% | 32.79M |
| Q3 FY1994 | 30 Sept 1994 | 32.50M | +32.41% | 32.50M |
| Q2 FY1994 | 30 Jun 1994 | 30.56M | +14.58% | 30.56M |
| Q1 FY1994 | 31 Mar 1994 | 29.09M | +23.42% | 29.09M |
| Q4 FY1993 | 31 Dec 1993 | 29.09M | +23.42% | 28.21M |
| Q3 FY1993 | 30 Sept 1993 | 24.55M | +0.41% | 24.55M |
| Q2 FY1993 | 30 Jun 1993 | 26.67M | +12.28% | 26.67M |
| Q1 FY1993 | 31 Mar 1993 | 23.57M | +3.13% | 23.57M |
| Q4 FY1992 | 31 Dec 1992 | 23.57M | +3.13% | 23.57M |
| Q3 FY1992 | 30 Sept 1992 | 24.44M | +42.59% | 24.44M |
| Q2 FY1992 | 30 Jun 1992 | 23.75M | +20.71% | 23.75M |
| Q1 FY1992 | 31 Mar 1992 | 22.86M | +16.17% | 22.86M |
| Q4 FY1991 | 31 Dec 1991 | 22.86M | +16.17% | 22.86M |
| Q3 FY1991 | 30 Sept 1991 | 17.14M | -12.87% | 17.14M |
| Q2 FY1991 | 30 Jun 1991 | 19.68M | 0.00% | 19.68M |
| Q1 FY1991 | 31 Mar 1991 | 19.68M | 0.00% | 19.68M |
| Q4 FY1990 | 31 Dec 1990 | 19.68M | — | 19.68M |
| Q3 FY1990 | 30 Sept 1990 | 19.68M | — | 19.68M |
| Q2 FY1990 | 30 Jun 1990 | 19.68M | — | 19.68M |
| Q1 FY1990 | 31 Mar 1990 | 19.68M | — | 19.68M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Vertex Pharmaceuticals's shares
Source: Financial Modeling Prep